Tempus AI, Inc. (NASDAQ:TEM – Get Free Report) has earned an average rating of “Moderate Buy” from the thirteen brokerages that are presently covering the firm, Marketbeat reports. Six analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 12 month price objective among brokers that have issued ratings on the stock in the last year is $71.8333.
A number of brokerages have recently issued reports on TEM. Morgan Stanley lifted their price objective on shares of Tempus AI from $65.00 to $68.00 and gave the stock an “overweight” rating in a research report on Tuesday, August 12th. Piper Sandler reaffirmed a “neutral” rating on shares of Tempus AI in a research report on Friday, August 8th. Guggenheim lifted their price objective on shares of Tempus AI from $80.00 to $95.00 and gave the stock a “buy” rating in a research report on Friday, September 26th. HC Wainwright lifted their price objective on shares of Tempus AI from $90.00 to $98.00 and gave the stock a “buy” rating in a research report on Friday, September 12th. Finally, Needham & Company LLC reaffirmed a “buy” rating and issued a $70.00 price objective on shares of Tempus AI in a research report on Friday, August 8th.
Get Tempus AI alerts:
Read Our Latest Analysis on Tempus AI
Insider Activity at Tempus AI
In other Tempus AI news, CEO Eric P. Lefkofsky sold 332,500 shares of Tempus AI stock in a transaction that occurred on Thursday, September 25th. The shares were sold at an average price of $76.56, for a total transaction of $25,456,200.00. Following the completion of the sale, the chief executive officer directly owned 9,141,032 shares in the company, valued at approximately $699,837,409.92. The trade was a 3.51% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, COO Ryan Fukushima sold 17,460 shares of Tempus AI stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $74.65, for a total transaction of $1,303,389.00. Following the sale, the chief operating officer owned 839,180 shares of the company’s stock, valued at approximately $62,644,787. The trade was a 2.04% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 933,662 shares of company stock worth $67,909,393 in the last 90 days. 26.27% of the stock is owned by insiders.
Institutional Trading of Tempus AI
Several institutional investors and hedge funds have recently bought and sold shares of TEM. Vanguard Group Inc. lifted its stake in Tempus AI by 6,247.5% during the 1st quarter. Vanguard Group Inc. now owns 5,995,117 shares of the company’s stock valued at $289,204,000 after acquiring an additional 5,900,668 shares during the period. ARK Investment Management LLC lifted its stake in Tempus AI by 35.9% during the 1st quarter. ARK Investment Management LLC now owns 7,501,399 shares of the company’s stock valued at $361,867,000 after acquiring an additional 1,981,755 shares during the period. Nikko Asset Management Americas Inc. lifted its stake in Tempus AI by 31.5% during the 1st quarter. Nikko Asset Management Americas Inc. now owns 4,260,553 shares of the company’s stock valued at $205,401,000 after acquiring an additional 1,021,460 shares during the period. Sumitomo Mitsui Trust Group Inc. lifted its stake in Tempus AI by 31.4% during the 1st quarter. Sumitomo Mitsui Trust Group Inc. now owns 4,255,477 shares of the company’s stock valued at $205,284,000 after acquiring an additional 1,016,384 shares during the period. Finally, AQR Capital Management LLC acquired a new stake in Tempus AI during the 2nd quarter valued at approximately $54,020,000. 24.22% of the stock is currently owned by institutional investors and hedge funds.
Tempus AI Trading Up 9.0%
NASDAQ TEM opened at $87.99 on Thursday. The company has a debt-to-equity ratio of 2.58, a quick ratio of 1.43 and a current ratio of 1.54. The company has a market capitalization of $15.29 billion, a price-to-earnings ratio of -73.94 and a beta of 4.89. The company’s 50-day simple moving average is $73.92 and its two-hundred day simple moving average is $62.59. Tempus AI has a one year low of $31.36 and a one year high of $97.79.
Tempus AI (NASDAQ:TEM – Get Free Report) last issued its quarterly earnings data on Friday, August 8th. The company reported ($0.22) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.23) by $0.01. Tempus AI had a negative net margin of 20.98% and a negative return on equity of 122.86%. The firm had revenue of $314.64 million for the quarter, compared to the consensus estimate of $296.84 million. During the same quarter in the previous year, the firm earned ($6.86) EPS. The company’s quarterly revenue was up 89.5% compared to the same quarter last year. Tempus AI has set its FY 2025 guidance at EPS. Equities analysts forecast that Tempus AI will post -6.15 EPS for the current fiscal year.
About Tempus AI
(Get Free Report)
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Read More
Five stocks we like better than Tempus AI
Most Volatile Stocks, What Investors Need to Know
Datavault AI: The New AI Contender Backed by Big Funding
Trading Halts Explained
CoreWeave: Why the New King of AI Infrastructure Has Room to Run
Options Trading – Understanding Strike Price
Top 3 Dividend Achievers for October: High Yields, Growth Ahead